Dapsone hypersensitivity syndrome not related to G6PD deficiency

Karlijn J G Schulkes, J W Cohen Tervaert, Feiko Rijken, Lenneke E M Haas

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Dapsone hypersensitivity syndrome (DHS) is a rare, but potentially life-threatening reaction to dapsone. We describe a 55-year-old Caucasian woman with normal glucose-6-phosphate dehydrogenase levels presenting with an extensive skin eruption, high-grade fever, pneumonitis and hepatitis, which occurred within 3 weeks after initiation of dapsone. In addition to supportive care, the patient was successfully treated with high-dose corticosteroids and antibiotics. The combination of high-grade fever, skin rash, lung and liver involvement made a dapsone hypersensitivity syndrome very likely.

Original languageEnglish
JournalBMJ Case Reports [E]
Volume2015
DOIs
Publication statusPublished - 18 Dec 2015

Keywords

  • Anti-Infective Agents
  • Chemical and Drug Induced Liver Injury
  • Dapsone
  • Diagnosis, Differential
  • Drug Hypersensitivity Syndrome
  • Female
  • Glucosephosphate Dehydrogenase
  • Glucosephosphate Dehydrogenase Deficiency
  • Humans
  • Middle Aged
  • Pneumonia
  • Vasculitis
  • Case Reports
  • Journal Article

Fingerprint

Dive into the research topics of 'Dapsone hypersensitivity syndrome not related to G6PD deficiency'. Together they form a unique fingerprint.

Cite this